S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern

Syndax Pharmaceuticals (SNDX) SEC Filings & 10K Form

$21.72
-0.60 (-2.69%)
(As of 04/12/2024 08:52 PM ET)

Recent Syndax Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/18/2024
6:10 AM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
4:21 PM
Syndax Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
4:28 PM
Syndax Pharmaceuticals (Filer)
Form S-3ASR
02/27/2024
3:33 PM
Syndax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
11:50 AM
Kynam Capital Management, LP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G
02/14/2024
6:01 AM
Point72 Asset Management, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
8:44 PM
Avidity Partners Management LP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
9:18 AM
Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/25/2024
10:20 AM
STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
12/20/2023
7:40 AM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
4:29 PM
Syndax Pharmaceuticals (Filer)
Form 424B5
12/15/2023
4:29 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
3:30 PM
Syndax Pharmaceuticals (Filer)
Form 424B5
10/05/2023
11:23 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2023
6:04 AM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
5:50 AM
Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
8:12 AM
Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
5:26 PM
Meury William (Reporting)
Syndax Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2023
6:07 AM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
8:23 AM
Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:12 PM
Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
3:20 PM
Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:32 PM
Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
3:39 PM
Syndax Pharmaceuticals (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNDX) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners